Sulfiredoxin-1 Attenuates Oxidative Stress via Nrf2/ARE Pathway and 2-Cys Prdxs After Oxygen-Glucose Deprivation in Astrocytes

详细信息    查看全文

• 作者：Yang Zhou ; Song Duan ; Yunchuan Zhou ; Shanshan Yu…
• 关键词：Sulfiredoxin ; 1 ; Astrocytes ; Oxidative stress ; OGD ; Nrf2/ARE pathway ; 2 ; Cys Prdxs
• 刊名：Journal of Molecular Neuroscience
• 出版年：2015
• 出版时间：April 2015
• 年：2015
• 卷：55
• 期：4
• 页码：941-950
• 全文大小：1,117 KB
• 参考文献：1. Alfieri, A, Srivastava, S, Siow, RC, Modo, M, Fraser, PA, Mann, GE (2011) Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke. J Physiol 589: pp. 4125-4136 CrossRef
  2. Bae, SH, Sung, SH, Lee, HE, Kang, HT, Lee, SK, Oh, SY, Woo, HA, Kil, IS, Rhee, SG (2012) Peroxiredoxin III and sulfiredoxin together protect mice from pyrazole-induced oxidative liver injury. Antioxid Redox Signal 17: pp. 1351-1361 CrossRef
  3. Baek, JY, Han, SH, Sung, SH, Lee, HE, Y-m, K, Noh, YH, Bae, SH, Rhee, SG, Chang, T-S (2012) Sulfiredoxin protein is critical for redox balance and survival of cells exposed to low steady-state levels of H2O2. J Biol Chem 287: pp. 81-89 CrossRef
  4. Barreto, G, White, RE, Ouyang, Y, Xu, L, Giffard, RG (2011) Astrocytes: targets for neuroprotection in stroke. Cent Nerv Syst Agents Med Chem 11: pp. 164-173 CrossRef
  5. Biteau, B, Labarre, J, Toledano, MB (2003) ATP-dependent reduction of cysteine–sulphinic acid by S. cerevisiae sulphiredoxin. Nature 425: pp. 980-984 CrossRef
  6. Blackwood, EM, Kadonaga, JT (1998) Going the distance: a current view of enhancer action. Science 281: pp. 60-63 CrossRef
  7. Botia, B, Seyer, D, Ravni, A, Benard, M, Falluel-Morel, A, Cosette, P, Jouenne, T, Fournier, A, Vaudry, H, Gonzalez, BJ, Vaudry, D (2008) Peroxiredoxin 2 is involved in the neuroprotective effects of PACAP in cultured cerebellar granule neurons. J Mol Neurosci 36: pp. 61-72 CrossRef
  8. Bruno, V, Goldberg, M, Dugan, L, Giffard, R, Choi, D (1994) Neuroprotective effect of hypothermia in cortical cultures exposed to oxygen‐glucose deprivation or excitatory amino acids. J Neurochem 63: pp. 1398-1406 CrossRef
  9. Calkins, MJ, Jakel, RJ, Johnson, DA, Chan, K, Kan, YW, Johnson, JA (2005) Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc Natl Acad Sci U S A 102: pp. 244-249 CrossRef
  10. Chang, T-S, Jeong, W, Woo, HA, Lee, SM, Park, S, Rhee, SG (2004) Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine. J Biol Chem 279: pp. 50994-51001 CrossRef
  11. Coyle, JT, Puttfarcken, P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: pp. 689-695 CrossRef
  12. Cullinan, SB, Gordan, JD, Jin, J, Harper, JW, Diehl, JA (2004) The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol Cell Biol 24: pp. 8477-8486 CrossRef
  13. Danbolt, NC (1994) The high affinity uptake system for excitatory amino acids in the brain. Prog Neurobiol 44: pp. 377-396 CrossRef
  14. Fang, J, Nakamura, T, Cho, D-H, Gu, Z, Lipton, SA (2007) S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson’s disease. Proc Natl Acad Sci 104: pp. 18742-18747 CrossRef
  15. Favreau, L, Pickett, C (1991) Transcriptional regulation of the rat NAD (P) H: quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants. J Biol Chem 266: pp. 4556-4561
  16. F
• 刊物主题：Neurosciences; Neurochemistry; Cell Biology; Proteomics; Neurology;
• 出版者：Springer US
• ISSN：1559-1166

文摘

Sulfiredoxin-1 (Srxn1), an endogenous antioxidant protein, is involved in keeping the balance of the cell’s oxidation/reduction and can resist oxidative stress. However, the exact antioxidant effects of Srxn1 remain fully unclear. The study aims to examine the effects of Srxn1 on oxidative stress and explore the potential mechanisms in astrocytes with 6?h/oxygen-glucose deprivation (OGD), 24?h/respiration. In the study, silencing Srxn1 was performed before exposure to 6?h/OGD, 24?h/respiration in primary astrocytes. Decreased cell viability and increased cellular damage measured by CellTiter 96H AQueous Non-Radioactive Cell Proliferation Assay (MTS) and lactate dehydrogenase (LDH) were observed in Srxn1 silencing astrocytes. In addition, Srxn1 silencing resulted in a decrease in both intracellular superoxide dismutase (SOD) and glutathione (GSH). NF-E2-related factor 2 (Nrf2), a transcription factor known to influence susceptibility to oxidative stress, upregulated Srxn1 expression during oxidative stress caused by OGD in the astrocytes. Electromobility shift assay (EMSA) demonstrated a decreased binding of Nrf2 to oligomers containing Srxn1 ter-specific antioxidant response element (ARE)-binding site in Nrf2 silencing astrocytes. We also found that a reduction of peroxiredoxin (Prdx)-SO3 was closely dependent on Srxn1. In addition, 2-Cys Prdxs protein levels were increased in the astrocytes exposed to OGD, as evaluated by immunoblot analysis. All taken together, the study suggested that silencing Srxn1 would result into increasing sensitivity to OGD-induced oxidative stress injury in astrocytes. Furthermore, Nrf2/ARE pathway was involved into Srxn1, playing its antioxidant protection against oxidative stress, all of which would provide a novel therapeutic theory for treating acute ischemic brain injury.